C-OAXVgenetic medicines, non-viral delivery, senescent cell removal
Editor’s Choice. Hand-picked by the Eternal Search editors as worth your attention — a curatorial call shown alongside, not instead of, the computed score.
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Patents are split by ownership. Held by the company are assigned to this organization. Field corridor patents are held by others in the same technical area — shown to map the freedom-to-operate landscape, not company-owned IP.
Patents assigned to this organization.
WO2019178613A1 - B cells genetically engineered to secrete follistatin and methods of using the same to treat follistatin-related diseases, conditions, disorders and to enhance muscle growth and strength - Google Patents WO2019178613A1 - B…
WO2014160661A3 - Systems and methods for the targeted production of a therapeutic protein within a target cell - Google Patents WO2014160661A3 - Systems and methods for the targeted production of a therapeutic protein within a target cell -…
HK1218935A1 - 靶細胞內治療性蛋白的靶向產生的系統和方法 - Google Patents HK1218935A1 - 靶細胞內治療性蛋白的靶向產生的系統和方法 - Google Patents 靶細胞內治療性蛋白的靶向產生的系統和方法 Download PDF Info Publication number HK1218935A1 HK1218935A1 HK16106874.0A HK16106874A HK1218935A1 HK 1218935 A1 HK…
WO2023056070A2 - Compositions and methods for liver-specific expression of follistatin - Google Patents WO2023056070A2 - Compositions and methods for liver-specific expression of follistatin - Google Patents Compositions and methods for liv…
WO2012040825A1 - Recombinant polypeptides for membrane fusion and uses thereof - Google Patents WO2012040825A1 - Recombinant polypeptides for membrane fusion and uses thereof - Google Patents Recombinant polypeptides for membrane fusion and…
US20200109419A1 - Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a disease, condition, or disorder associated with a ta…
WO2019204666A1 - Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a disease, condition, or disorder associated with a tar…
US11603543B2 - Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein - Google Patents US11603543B2 - Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein - Google Pa…
US20160010110A1 - Systems and methods for the targeted production of a therapeutic protein within a target cell - Google Patents US20160010110A1 - Systems and methods for the targeted production of a therapeutic protein within a target cell…
Blocking or adjacent IP in the same technical area, owned by third parties. Not affiliated with this organization.
WO2017091547A1 - Methods and compositions for reprogramming cells - Google Patents WO2017091547A1 - Methods and compositions for reprogramming cells - Google Patents Methods and compositions for reprogramming cells Download PDF Info Publica…
WO2020214986A1 - Embryogenesis factors for cellular reprogramming of a plant cell - Google Patents WO2020214986A1 - Embryogenesis factors for cellular reprogramming of a plant cell - Google Patents Embryogenesis factors for cellular reprogr…
US20190017032A1 - Cell reprogramming - Google Patents US20190017032A1 - Cell reprogramming - Google Patents Cell reprogramming Download PDF Info Publication number US20190017032A1 US20190017032A1 US16/064,905 US201616064905A US2019017032A1…
US20160250260A1 - Small molecule cellular reprogramming to generate neuronal cells - Google Patents US20160250260A1 - Small molecule cellular reprogramming to generate neuronal cells - Google Patents Small molecule cellular reprogramming to…
US20200263189A1 - Systems and methods for cellular reprogramming of a plant cell - Google Patents US20200263189A1 - Systems and methods for cellular reprogramming of a plant cell - Google Patents Systems and methods for cellular reprogrammi…
WO2019075057A1 - Cellular reprogramming using temporal and transient plasmid vector expression system - Google Patents WO2019075057A1 - Cellular reprogramming using temporal and transient plasmid vector expression system - Google Patents Ce…
EP3806873A1 - Reprogramming cells with synthetic messenger rna - Google Patents EP3806873A1 - Reprogramming cells with synthetic messenger rna - Google Patents Reprogramming cells with synthetic messenger rna Info Publication number EP38068…
WO2020069373A1 - Cellular reprogramming to reverse aging and promote organ and tissue regeneration - Google Patents WO2020069373A1 - Cellular reprogramming to reverse aging and promote organ and tissue regeneration - Google Patents Cellular…
WO2015163823A1 - Methods of cellular reprogramming - Google Patents WO2015163823A1 - Methods of cellular reprogramming - Google Patents Methods of cellular reprogramming Download PDF Info Publication number WO2015163823A1 WO2015163823A1 PCT…
WO2019178296A1 - Transient cellular reprogramming for reversal of cell aging - Google Patents WO2019178296A1 - Transient cellular reprogramming for reversal of cell aging - Google Patents Transient cellular reprogramming for reversal of cel…
US20070269537A1 - Skin Condition Improvement Including Acne, Rosacea, and Topical Wounds by Artemisia Annua Extract via Iron Siderophore Trojan Horse Delivery System - Google Patents US20070269537A1 - Skin Condition Improvement Including Ac…
US20210138043A1 - Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase - Google Patents US20210138043A1 - Compounds and methods for the immobilization of myostatin-inhibitors o…
WO2020025710A1 - Micro rna for use in the prevention and/or treatment of invasive cancer - Google Patents WO2020025710A1 - Micro rna for use in the prevention and/or treatment of invasive cancer - Google Patents Micro rna for use in the pre…
WO2016156526A1 - Immunoassay for collagen type vi sequence - Google Patents WO2016156526A1 - Immunoassay for collagen type vi sequence - Google Patents Immunoassay for collagen type vi sequence Download PDF Info Publication number WO2016156…
WO2007104242A1 - Composés capables d'inhiber les métalloprotéinases à ion de zinc - Google Patents WO2007104242A1 - Composés capables d'inhiber les métalloprotéinases à ion de zinc - Google Patents Composés capables d'inhiber le…
WO2022055334A1 - Composition de prévention ou de traitement de la maladie de la fibrose pulmonaire - Google Patents WO2022055334A1 - Composition de prévention ou de traitement de la maladie de la fibrose pulmonaire - Google Patents Composit…
US9364516B2 - Treatment of fibrosis-related disorders using fibronectin binding proteins and polypeptides - Google Patents US9364516B2 - Treatment of fibrosis-related disorders using fibronectin binding proteins and polypeptides - Google Pa…
WO2021231956A1 - Fast automated approach for the derivation of acellular extracellular matrix scaffolds from tissues - Google Patents WO2021231956A1 - Fast automated approach for the derivation of acellular extracellular matrix scaffolds fr…
WO2012142569A2 - Decellularized extracellular matrix - Google Patents WO2012142569A2 - Decellularized extracellular matrix - Google Patents Decellularized extracellular matrix Download PDF Info Publication number WO2012142569A2 WO2012142569…
US9744265B2 - 3-Dimensional cardiac fibroblast derived extracellular matrix - Google Patents US9744265B2 - 3-Dimensional cardiac fibroblast derived extracellular matrix - Google Patents 3-Dimensional cardiac fibroblast derived extracellular…
US10722560B2 - Compositions for remodeling extracellular matrix and methods of use thereof - Google Patents US10722560B2 - Compositions for remodeling extracellular matrix and methods of use thereof - Google Patents Compositions for remodel…
EP3572089A1 - Anti-aging method and composition - Google Patents EP3572089A1 - Anti-aging method and composition - Google Patents Anti-aging method and composition Download PDF Info Publication number EP3572089A1 EP3572089A1 EP19176647.6A E…
WO2020092117A2 - Killing senescent cells and treating senescence-associated diseases or disorders using a combination of a bcl inhibitor and an mcl-1 inhibitor - Google Patents WO2020092117A2 - Killing senescent cells and treating senescenc…
WO2015116735A1 - Methods and combinations for killing senescent cells and for treating senescence-associated diseases and disorders - Google Patents WO2015116735A1 - Methods and combinations for killing senescent cells and for treating sene…
EP4326903A1 - Methods and compositions for treating cell senescence accumulation related disease - Google Patents EP4326903A1 - Methods and compositions for treating cell senescence accumulation related disease - Google Patents Methods and…
WO2016118014A2 - Anti-senescence compounds and uses thereof - Google Patents WO2016118014A2 - Anti-senescence compounds and uses thereof - Google Patents Anti-senescence compounds and uses thereof Download PDF Info Publication number WO2016…
EP4654998A2 - T cell-directed anti-aging and anti-cancer vaccines against commensal cytomegalovirus - Google Patents EP4654998A2 - T cell-directed anti-aging and anti-cancer vaccines against commensal cytomegalovirus - Google Patents T cell…
US10478432B2 - Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye - Google Patents US10478432B2 - Compositions of matter for treatment of ophthalmic conditions by selectively r…
WO2025242858A1 - Composition for selective elimination of senescent cells - Google Patents WO2025242858A1 - Composition for selective elimination of senescent cells - Google Patents Composition for selective elimination of senescent cells I…
CN117915953A - Screening method for senescent cell clearing drug and senescent cell clearing drug - Google Patents CN117915953A - Screening method for senescent cell clearing drug and senescent cell clearing drug - Google Patents Screening…
US20200316066A1 - Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid - Google Patents US20200316066A1 - Killing senescent cells and treating senescence-associated conditions using a s…